Literature DB >> 35583716

The Unconventional Growth Factors Cerebral Dopamine Neurotrophic Factor and Mesencephalic Astrocyte-Derived Neurotrophic Factor Promote Post-ischemic Neurological Recovery, Perilesional Brain Remodeling, and Lesion-Remote Axonal Plasticity.

Ahmet Burak Caglayan1,2,3, Mustafa Caglar Beker3,4, Elif Sertel Evren3,4, Berrak Caglayan3,5, Ülkan Kilic6, Nilay Ates3,7, Aysun Caglayan3,4, Muhammed Furkan Dasdelen3,4, Thorsten Roland Doeppner3,8,9, Mart Saarma10, Dirk Matthias Hermann11, Ertugrul Kilic12,13.   

Abstract

Considerable efforts are currently made to develop strategies that boost endogenous recovery once a stroke has occurred. Owing to their restorative properties, neurotrophic factors are attractive candidates that capitalize on endogenous response mechanisms. Non-conventional growth factors cerebral dopamine neurotrophic factor (CDNF) and mesencephalic astrocyte-derived neurotrophic factor (MANF) promote neuronal survival and reduce neurological deficits in the acute phase of ischemic stroke in mice. Their effects on endogenous repair and recovery mechanisms in the stroke recovery phase were so far unknown. By intracerebroventricular delivery of CDNF or MANF starting 3 days post-stroke (1 µg/day for 28 days via miniosmotic pumps), we show that delayed CDNF and MANF administration promoted functional neurological recovery assessed by a battery of behavioral tests, increased long-term neuronal survival, reduced delayed brain atrophy, glial scar formation, and, in case of CDNF but not MANF, increased endogenous neurogenesis in the perilesional brain tissue. Besides, CDNF and MANF administration increased long-distance outgrowth of terminal axons emanating from the contralesional pyramidal tract, which crossed the midline to innervate ipsilesional facial nucleus. This plasticity promoting effect was accompanied by downregulation of the axonal growth inhibitor versican and the guidance molecules ephrin B1 and B2 in the previously ischemic hemisphere at 14 dpi, which represents a sensitive time-point for axonal growth. CDNF and MANF reduced the expression of the proinflammatory cytokines IL1β and TNFα in both hemispheres. The effects of non-conventional growth factors in the ischemic brain should further be examined since they might help to identify targets for restorative stroke therapy.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Axonal sprouting; CDNF; Focal cerebral ischemia; Ischemic stroke; MANF; Unconventional growth factor

Year:  2022        PMID: 35583716     DOI: 10.1007/s12975-022-01035-2

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  43 in total

1.  Post-acute delivery of erythropoietin induces stroke recovery by promoting perilesional tissue remodelling and contralesional pyramidal tract plasticity.

Authors:  Raluca Reitmeir; Ertugrul Kilic; Ulkan Kilic; Marco Bacigaluppi; Ayman ElAli; Giuliana Salani; Stefano Pluchino; Max Gassmann; Dirk M Hermann
Journal:  Brain       Date:  2011-01       Impact factor: 13.501

2.  Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms.

Authors:  Marco Bacigaluppi; Stefano Pluchino; Luca Peruzzotti-Jametti; Luca Peruzzotti Jametti; Ertugrul Kilic; Ulkan Kilic; Giuliana Salani; Elena Brambilla; Mark J West; Giancarlo Comi; Gianvito Martino; Dirk M Hermann
Journal:  Brain       Date:  2009-07-16       Impact factor: 13.501

Review 3.  The science of stroke: mechanisms in search of treatments.

Authors:  Michael A Moskowitz; Eng H Lo; Costantino Iadecola
Journal:  Neuron       Date:  2010-07-29       Impact factor: 17.173

Review 4.  Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation.

Authors:  Dirk M Hermann; Michael Chopp
Journal:  Lancet Neurol       Date:  2012-03-19       Impact factor: 44.182

5.  Rewiring of the corticospinal tract in the adult rat after unilateral stroke and anti-Nogo-A therapy.

Authors:  Nicolas T Lindau; Balthasar J Bänninger; Miriam Gullo; Nicolas A Good; Lukas C Bachmann; Michelle L Starkey; Martin E Schwab
Journal:  Brain       Date:  2013-12-18       Impact factor: 13.501

6.  Vascular endothelial growth factor induces contralesional corticobulbar plasticity and functional neurological recovery in the ischemic brain.

Authors:  Raluca Reitmeir; Ertugrul Kilic; Barbara S Reinboth; Zeyun Guo; Ayman ElAli; Anil Zechariah; Ulkan Kilic; Dirk M Hermann
Journal:  Acta Neuropathol       Date:  2011-11-23       Impact factor: 17.088

Review 7.  Management of acute ischemic stroke.

Authors:  Michael S Phipps; Carolyn A Cronin
Journal:  BMJ       Date:  2020-02-13

8.  Evidence for stroke-induced neurogenesis in the human brain.

Authors:  Kunlin Jin; Xiaomei Wang; Lin Xie; Xiao Ou Mao; Wei Zhu; Yin Wang; Jianfeng Shen; Ying Mao; Surita Banwait; David A Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

Review 9.  Neuroinflammation: friend and foe for ischemic stroke.

Authors:  Richard L Jayaraj; Sheikh Azimullah; Rami Beiram; Fakhreya Y Jalal; Gary A Rosenberg
Journal:  J Neuroinflammation       Date:  2019-07-10       Impact factor: 8.322

Review 10.  Neurogenesis After Stroke: A Therapeutic Perspective.

Authors:  Abir A Rahman; Narayanappa Amruta; Emmanuel Pinteaux; Gregory J Bix
Journal:  Transl Stroke Res       Date:  2020-08-29       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.